Circulating tumour cells (CTCs) have potential utility in various clinical applications for
cancer management. The present study focused on evaluating the diagnostic role of CTCs …

BACKGROUND. Bladder cancer is among the 5 most common malignancies worldwide.
Patients with bladder cancer are closely followed with periodic cystoscopies and urine …

Eight million people die of cancer each year and 90% of deaths are caused by systemic
disease. Circulating tumor cells (CTCs) contribute to the formation of metastases and thus …

Recent cancer research has demonstrated the existence of circulating tumor cells (CTCs) in
cancer patient's blood. Once identified, CTC biomarkers will be invaluable tools for clinical …

The objective of this study was to evaluate the potential detection of circulating tumor cells
(CTCs) using the CellSearch (CS) Assay™ in patients with locally advanced head and neck …

Introduction. Liquid biopsies are noninvasive tests using blood or body fluids to detect
circulating tumor cells (CTCs) or the products of tumor cells, such as fragments of nucleic …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Enumeration and characterization of circulating tumor cells (CTC) hold the promise of a real
time liquid biopsy. They are however present in a large background of hematopoietic cells …

Abstract Comparison of two methods to detect circulating tumor cells (CTC) CytoTrack and
CellSearch through recovery of MCF-7 breast cancer cells, spiked into blood collected from …

BACKGROUND Research on circulating tumor cells (CTCs) as new biomarkers has
received great attention over the past decade. In particular, the capture and analysis of …